Long-Term Outcomes of IgA Nephropathy Presenting with Minimal or No Proteinuria

被引:156
作者
Gutierrez, Eduardo [1 ]
Zamora, Isabel [2 ]
Antonio Ballarin, Jose [3 ]
Arce, Yolanda [3 ]
Jimenez, Sara [4 ]
Quereda, Carlos [4 ]
Olea, Teresa [5 ]
Martinez-Ara, Jorge [5 ]
Segarra, Alfons [6 ]
Bernis, Carmen [7 ]
Garcia, Asuncion [7 ]
Goicoechea, Marian [8 ]
Garcia de Vinuesa, Soledad [8 ]
Rojas-Rivera, Jorge [1 ]
Praga, Manuel [1 ]
机构
[1] Inst Invest Hosp 12 Octubre I 12, Dept Nephrol, Madrid, Spain
[2] Hosp Univ La Fe, Dept Nephrol, Valencia, Spain
[3] Fdn Puigvert, Dept Nephrol & Pathol, Barcelona, Spain
[4] Hosp Univ Ramon & Cajal, Dept Nephrol, Madrid, Spain
[5] Hosp Univ La Paz, Dept Nephrol, Madrid, Spain
[6] Hosp Univ Vall Hebron, Dept Nephrol, Barcelona, Spain
[7] Hosp Univ La Princesa, Dept Nephrol & Pathol, Madrid, Spain
[8] Hosp Gen Univ Gregorio Maranon, Dept Nephrol, Madrid, Spain
来源
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2012年 / 23卷 / 10期
关键词
IMMUNOGLOBULIN-A NEPHROPATHY; PROGNOSTIC-FACTORS; NATURAL-HISTORY; PREDICTING PROGRESSION; OXFORD CLASSIFICATION; ASSOCIATION; THERAPY; TRIAL; GLOMERULONEPHRITIS; INHIBITORS;
D O I
10.1681/ASN.2012010063
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
The long-term outcome of patients with IgA nephropathy who present with normal renal function, microscopic hematuria, and minimal or no proteinuria is not well described. Here, we studied 141 Caucasian patients with biopsy-proven IgA nephropathy who had minor abnormalities at presentation and a median follow-up of 108 months. None of the patients received corticosteroids or immunosuppressants. We reviewed renal biopsies using the Oxford classification criteria. In this sample, 46 (32%) patients had mesangial proliferation, whereas endocapillary proliferation, focal glomerulosclerosis, and tubulointerstitial abnormalities were uncommon. Serum creatinine increases >50% and >100% were observed in five (3.5%) patients and one (0.7%) patient, respectively; no patients developed ESRD. After 10, 15, and 20 years, 96.7%, 91.9%, and 91.9% of patients maintained serum creatinine values less than a 50% increase, respectively. Using Cox proportional hazards regression, the presence of segmental glomerulosclerosis was the only factor that significantly associated with a >50% increase in serum creatinine. Clinical remission occurred in 53 (37.5%) patients after a median of 48 months. Proteinuria>0.5 and >1.0 g/24 h developed in 21 (14.9%) and 6 (4.2%) patients, respectively. Median proteinuria at the end of follow-up was 0.1 g/24 h, with 41(29.1%) patients having no proteinuria. At presentation, 23 (16.3%) patients were hypertensive compared with 30 (21.3%) patients at the end of follow-up; 59 (41.8%) patients were treated with renin-angiotensin blockers because of hypertension or increasing proteinuria. In summary, the long-term prognosis for Caucasian patients with IgA nephropathy who present with minor urinary abnormalities and normal renal function is excellent.
引用
收藏
页码:1753 / 1760
页数:8
相关论文
共 30 条
[1]  
ALAMARTINE E, 1990, CLIN NEPHROL, V34, P45
[2]   PROGNOSTIC FACTORS IN MESANGIAL IGA GLOMERULONEPHRITIS - AN EXTENSIVE STUDY WITH UNIVARIATE AND MULTIVARIATE ANALYSES [J].
ALAMARTINE, E ;
SABATIER, JC ;
GUERIN, C ;
BERLIET, JM ;
BERTHOUX, F .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1991, 18 (01) :12-19
[3]   The IgA nephropathy treatment dilemma [J].
Appel, G. B. ;
Waldman, M. .
KIDNEY INTERNATIONAL, 2006, 69 (11) :1939-1944
[4]   IgA nephropathy [J].
Barratt, J ;
Feehally, J .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2005, 16 (07) :2088-2097
[5]   Predicting progression in IgA nephropathy [J].
Bartosik, LP ;
Lajoie, G ;
Sugar, L ;
Cattran, DC .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2001, 38 (04) :728-735
[6]   Predicting the Risk for Dialysis or Death in IgA Nephropathy [J].
Berthoux, Francois ;
Mohey, Hesham ;
Laurent, Blandine ;
Mariat, Christophe ;
Afiani, Aida ;
Thibaudin, Lise .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2011, 22 (04) :752-761
[7]   Excessive body weight as a new independent risk factor for clinical and pathological progression in primary IgA nephritis [J].
Bonnet, F ;
Deprele, C ;
Sassolas, A ;
Moulin, P ;
Alamartine, E ;
Berthezène, F ;
Berthoux, F .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2001, 37 (04) :720-727
[8]   The Oxford classification of IgA nephropathy: rationale, clinicopathological correlations, and classification [J].
Cattran, Daniel C. ;
Coppo, Rosanna ;
Cook, H. Terence ;
Feehally, John ;
Roberts, Ian S. D. ;
Troyanov, Stephan ;
Alpers, Charles E. ;
Amore, Alessandro ;
Barratt, Jonathan ;
Berthoux, Francois ;
Bonsib, Stephen ;
Bruijn, Jan A. ;
D'Agati, Vivette ;
D'Amico, Giuseppe ;
Emancipator, Steven ;
Emma, Francesco ;
Ferrario, Franco ;
Fervenza, Fernando C. ;
Florquin, Sandrine ;
Fogo, Agnes ;
Geddes, Colin C. ;
Groene, Hermann-Josef ;
Haas, Mark ;
Herzenberg, Andrew M. ;
Hill, Prue A. ;
Hogg, Ronald J. ;
Hsu, Stephen I. ;
Jennette, J. Charles ;
Joh, Kensuke ;
Julian, Bruce A. ;
Kawamura, Tetsuya ;
Lai, Fernand M. ;
Leung, Chi Bon ;
Li, Lei-Shi ;
Li, Philip K. T. ;
Liu, Zhi-Hong ;
Mackinnon, Bruce ;
Mezzano, Sergio ;
Schena, F. Paolo ;
Tomino, Yasuhiko ;
Walker, Patrick D. ;
Wang, Haiyan ;
Weening, Jan J. ;
Yoshikawa, Nori ;
Zhang, Hong .
KIDNEY INTERNATIONAL, 2009, 76 (05) :534-545
[9]   LONG-TERM BENEFITS OF ANGIOTENSIN-CONVERTING ENZYME-INHIBITOR THERAPY IN PATIENTS WITH SEVERE IMMUNOGLOBULIN A NEPHROPATHY - A COMPARISON TO PATIENTS RECEIVING TREATMENT WITH OTHER ANTIHYPERTENSIVE AGENTS AND TO PATIENTS RECEIVING NO THERAPY [J].
CATTRAN, DC ;
GREENWOOD, C ;
RITCHIE, S .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1994, 23 (02) :247-254
[10]  
Coppo R, 2005, J NEPHROL, V18, P503